Compare LTC & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LTC | AXGN |
|---|---|---|
| Founded | 1992 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.7B |
| IPO Year | 1994 | 2013 |
| Metric | LTC | AXGN |
|---|---|---|
| Price | $38.38 | $30.55 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 8 |
| Target Price | ★ $39.00 | $37.63 |
| AVG Volume (30 Days) | 337.3K | ★ 804.7K |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | ★ 5.88% | N/A |
| EPS Growth | ★ 23.53 | N/A |
| EPS | ★ 2.52 | N/A |
| Revenue | ★ $262,854,000.00 | $225,208,000.00 |
| Revenue This Year | N/A | $19.81 |
| Revenue Next Year | $13.24 | $16.31 |
| P/E Ratio | $15.35 | ★ N/A |
| Revenue Growth | ★ 25.26 | 20.21 |
| 52 Week Low | $31.70 | $9.22 |
| 52 Week High | $40.80 | $36.00 |
| Indicator | LTC | AXGN |
|---|---|---|
| Relative Strength Index (RSI) | 45.78 | 43.86 |
| Support Level | $34.13 | $30.42 |
| Resistance Level | $40.05 | $34.26 |
| Average True Range (ATR) | 0.71 | 1.50 |
| MACD | -0.17 | 0.11 |
| Stochastic Oscillator | 22.64 | 44.60 |
LTC Properties Inc is a real estate investment trust. It invests in seniors housing and health care properties, mainly through ownership, sale-leasebacks, mortgage financing, joint ventures, construction financing, and structured finance solutions, including preferred equity, bridge, and mezzanine lending. The company's investment portfolio comprises several properties located throughout the USA, the majority of which are seniors housing and skilled nursing properties. The firm conducts and manages its business as two operating segments: Real Estate Investments, which generates maximum revenue, and SHOP.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.